Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus. (Q43089915)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Emilia Sato

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

G A Ferreira

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

21 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

927-934

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

Chemokines and leukocyte traffic

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Beneficial cardiovascular pleiotropic effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Statins and their role in vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

A novel anti-inflammatory role for simvastatin in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310364400

21 January 2018

Identifiers

DOI

10.1177/0961203310364400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20410153%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference